Involvement of iron-evoked oxidative stress in smoking-related endothelial dysfunction in healthy young men

PLoS ONE

Volumn 9, Issue 2, 2014, Pages

  Fukami, Kei ^a   Yamagishi, Sho Ichi ^a   Iida, Shuji ^a   Matsuoka, Hidehiro ^a   Okuda, Seiya ^a  

^a KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

DEFEROXAMINE MESYLATE; GLYCERYL TRINITRATE; IRON; IRON OXIDE; MALONALDEHYDE; DEFEROXAMINE; SIDEROPHORE;

ADULT; AGE; ARTICLE; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION COEFFICIENT; ENDOTHELIAL DYSFUNCTION; FLOW MEDIATED VASODILATATION; GENDER; HUMAN; IRON BLOOD LEVEL; LIPID OXIDATION; MALE; OXIDATIVE STRESS; SMOKING; TREATMENT DURATION; VASODILATATION; DRUG EFFECTS; INTRAVENOUS DRUG ADMINISTRATION; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; VASCULAR ENDOTHELIUM; YOUNG ADULT;

ADULT; DEFEROXAMINE; ENDOTHELIUM, VASCULAR; HUMANS; INFUSIONS, INTRAVENOUS; IRON; MALE; OXIDATIVE STRESS; SIDEROPHORES; SMOKING; VASODILATION; YOUNG ADULT;

EID: 84896786735     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0089433     Document Type: Article

References (28)

1. Davignon J, Ganz P (2004) Role of endothelial dysfunction in atherosclerosis. Circulation 109: III27-32. (Pubitemid 38786440)
2. Deanfield JE, Halcox JP, Rabelink TJ (2007) Endothelial function and dysfunction: testing and clinical relevance. Circulation 115: 1285-1295. (Pubitemid 46594773)
3. Yamagishi S, Ueda S, Nakamura K, Matsui T, Okuda S (2008) Role of asymmetric dimethylarginine (ADMA) in diabetic vascular complications. Curr Pharm Des 14: 2613-2618.
4. Fratta Pasini A, Albiero A, Stranieri C, Cominacini M, Pasini A, et al. (2012) Serum oxidative stress-induced repression of Nrf2 and GSH depletion: a mechanism potentially involved in endothelial dysfunction of young smokers. PLoS One 7: e30291.
5. Stirban A, Nandrean S, Kirana S, Götting C, Veresiu IA, et al. (2012) Benfotiamine counteracts smoking-induced vascular dysfunction in healthy smokers. Int J Vasc Med 2012: 968761.
6. Cai H, Harrison DG (2000) Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress. Circ Res 87: 840-844.
7. Ando R, Ueda S, Yamagishi S, Miyazaki H, Kaida Y, et al. (2013) Involvement of advanced glycation end product-induced asymmetric dimethylarginine generation in endothelial dysfunction. Diab Vasc Dis Res 10: 436-441.
8. Juni RP, Duckers HJ, Vanhoutte PM, Virmani R, Moens AL (2013) Oxidative stress and pathological changes after coronary artery interventions. J Am Coll Cardiol 61: 1471-1481.
9. Bo S, Ciccone G, Castiglione A, Gambino R, De Michieli F, et al. (2013) Anti-inflammatory and antioxidant effects of resveratrol in healthy smokers a randomized, double-blind, placebo-controlled, cross-over trial. Curr Med Chem 20: 1323-1331.
10. Seet RC, Lee CY, Loke WM, Huang SH, Huang H, et al. (2011) Biomarkers of oxidative damage in cigarette smokers: which biomarkers might reflect acute versus chronic oxidative stress? Free Radic Biol Med 50: 1787-1793.
11. Ganz T (2005) Cellular iron: ferroportin is the only way out. Cell Metab 1: 155-157.
12. Andrews NC (1999) Disorders of iron metabolism. N Engl J Med 341: 1986-1995.
13. Hentze MW, Muckenthaler MU, Andrews NC (2004) Balancing acts: molecular control of mammalian iron metabolism. Cell 117: 285-297. (Pubitemid 38534536)
14. Fontecave M, Pierre JL (1993) Iron: metabolism, toxicity and therapy. Biochimie 75: 767-773. (Pubitemid 23337715)
15. Tang YR, Zhang SQ, Xiong Y, Zhao Y, Fu H, et al. (2003) Studies of five microelement contents in human serum, hair, and fingernails correlated with aged hypertension and coronary heart disease. Biol Trace Elem Res 92: 97-104.
16. Tremblay AJ, Morrissette H, Gagné JM, Bergeron J, Gagné C, et al. (2004) Validation of the Friedewald formula for the determination of low-density lipoprotein cholesterol compared with beta-quantification in a large population. Clin Biochem 37: 785-790. (Pubitemid 39141120)
17. Celermajer DS, Sorensen KE, Gooch VM, Spiegelhalter DJ, Miller OI, et al. (1992) Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet 340: 1111-1115.
18. Rooyakkers TM, Stroes ES, Kooistra MP, van Faassen EE, Hider RC, et al. (2002) Ferric saccharate induces oxygen radical stress and endothelial dysfunction in vivo. Eur J Clin Invest 32 Suppl 1: 9-16. (Pubitemid 41704982)
19. Ganguli A, Kohli HS, Khullar M, Lal Gupta K, Jha V, et al. (2009) Lipid peroxidation products formation with various intravenous iron preparations in chronic kidney disease. Ren Fail 31: 106-110.
20. Schaller G, Scheiber-Mojdehkar B, Wolzt M, Puttinger H, Mittermayer F, et al. (2005) Intravenous iron increases labile serum iron but does not impair forearm blood flow reactivity in dialysis patients. Kidney Int 68: 2814-2822. (Pubitemid 43251028)
21. Bolaños L, González-Juanatey C, Testa A, Ranero R (2008) Intravenous iron sucrose does not impair sonographic brachial vasodilation in peritoneal dialysis patients. Adv Perit Dial 24: 90-95.
22. Ozkurt S, Ozenc F, Degirmenci NA, Temiz G, Musmul A, et al. (2012) Acute and sub-acute effects of EV iron sucrose on endothelial functions in haemodialysis patients. Ren Fail 34: 1-6.
23. Drüeke T, Witko-Sarsat V, Massy Z, Descamps-Latscha B, Guerin AP, et al. (2002) Iron therapy, advanced oxidation protein products, and carotid artery intima-media thickness in end-stage renal disease. Circulation 106: 2212-2217. (Pubitemid 35222215)
24. Reis KA, Guz G, Ozdemir H, Erten Y, Atalay V, et al. (2005) Intravenous iron therapy as a possible risk factor for atherosclerosis in end-stage renal disease. Int Heart J 46: 255-264.
25. Duffy SJ, Biegelsen ES, Holbrook M, Russell JD, Gokce N, et al. (2001) Iron chelation improves endothelial function in patients with coronary artery disease. Circulation 103: 2799-2804. (Pubitemid 32550067)
26. Swarnalatha G, Ram R, Neela P, Naidu MU, Dakshina Murty KV (2010) Oxidative stress in haemodialysis patients receiving intravenous iron therapy and the role of N-acetylcysteine in preventing oxidative stress. Saudi J Kidney Dis Transpl 21: 852-858.
27. Poredos P, Jezovnik MK (2013) Testing endothelial function and its clinical relevance. J Atheroscler Thromb 20: 1-8.
28. Al-Qaisi M, Kharbanda RK, Mittal TK, Donald AE (2008) Measurement of endothelial function and its clinical utility for cardiovascular risk. Vasc Health Risk Manag 4: 647-652. (Pubitemid 352037922)